Start Forschung Personen

Personen

Anna Becker

Tel.: 0621 1703-2671

E-Mail

Therapiegebäude, EG, Altentagesklinik

Publikationen in peer-reviewed Zeitschriften seit 2006

TOP 5 Publikationen:

  1. Englisch S, Jung HS, Eisenacher S, Lewien A, Becker A, Nowak U, Braun H, Thiem J, Meyer-Lindenberg A, Zink M. Neurocognitive Effects of Agomelatine Treatment in Schizophrenia Patients Suffering From Comorbid Depression: Results From the AGOPSYCH Study. J Clin Psychopharmacol. 2018 38(4):357-361.
  2. Eisenacher S, Rausch F, Ainser F, Englisch S, Becker A, Mier D, Fenske S, Meyer-Lindenberg A, Kirsch P, Zink M. Early cognitive basic symptoms are accompanied by neurocognitive impairment in patients with an 'at-risk mental state' for psychosis. Early Interv Psychiatry. 2018 12(4):586-595. Epub 2016 May 12.
  3. Englisch S, Jung HS, Lewien A, Becker A, Nowak U, Braun H, Thiem J, Eisenacher S, Meyer-Lindenberg A, Zink M. Agomelatine for the Treatment of Major Depressive Episodes in Schizophrenia-Spectrum Disorders: An Open-Prospective Proof-of-Concept Study. J Clin Psychopharmacol. 2016 36(6):597-607. Epub 2016 Oct 29.
  4. Schneider BC, Brüne M, Bohn F, Veckenstedt R, Kolbeck K, Krieger E, Becker A, Drommelschmidt KA, Englisch S, Eisenacher S, Lee-Grimm SI, Nagel M, Zink M, Moritz S. Investigating the efficacy of an individualized metacognitive therapy program (MCT+) for psychosis: study protocol of a multi-center randomized controlled trial. BMC Psychiatry. 2016 16(1):51.
  5. Eisenacher S, Rausch F, Mier D, Fenske S, Veckenstedt R, Englisch S, Becker A, Andreou C, Moritz S, Meyer-Lindenberg A, Kirsch P, Zink M. Bias against disconfirmatory evidence in the 'at-risk mental state' and during psychosis. Psychiatry Res. 2016 238:242-50.


Zentralinstitut für Seelische Gesundheit (ZI) - https://www.zi-mannheim.de